Inhaled IL-2 induces systemic immunomodulation in patients with renal cell carcinoma and lung metastasis

By Diaz David  

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 2, 2009-02 ,pp. : 235-245

Springer Publishing Company

Access to resources Recommend Favorite

Elevation of soluble interleukin-2 receptor in patients with non-small cell lung cancer treated with gefitinib

By Kanazawa Shigenori   Yamaguchi Kazuyuki   Kinoshita Yoshimi   Komiyama Yutaka   Muramatsu Mikiko   Nomura Shosaku  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 11, 2006-11 ,pp. : 719-725

Springer Publishing Company

Access to resources Recommend Favorite

Metastatic renal cell carcinoma treated with Peg-interferon alfa-2b

By Lyrdal David   Stierner Ulrika   Lundstam Sven  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 901-908

Informa Healthcare

Access to resources Recommend Favorite

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

By Bennouna Jaafar   Bompas Emmanuelle   Neidhardt Eve   Rolland Frédéric   Philip Irène   Galéa Céline   Salot Samuel   Saiagh Soraya   Audrain Marie   Rimbert Marie   Lafaye-de Micheaux Sylvie   Tiollier Jérôme   Négrier Sylvie  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 11, 2008-11 ,pp. : 1599-1609

Springer Publishing Company

Access to resources Recommend Favorite

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC

By Konjević Gordana   Jović Viktor   Jurišić Vladimir   Radulović Siniša   Jelić Svetislav   Spužić Ivan  

Clinical and Experimental Metastasis, Vol. 20, Iss. 7, 2003-11 ,pp. : 647-655

Springer Publishing Company

Access to resources Recommend Favorite